Literature DB >> 6170376

Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs: effect of long-term treatment with sodium cromoglycate and aminophylline.

P Andersson, H Bergstrand.   

Abstract

1 The effects of long-term treatment with sodium cromoglycate (SCG) and aminophylline on antigen-induced bronchoconstriction have been studied in guinea-pigs actively sensitized according to two different regimens (one producing IgE- and IgG-like antibodies and the other producing exclusively IgG-like antibodies). 2 Treatment for three weeks with SCG (10 mg/kg) and aminophylline (10, 30 or 60 mg/kg) led to a decreased bronchial response capacity which persisted even three days after treatment ceased. In this respect SCG was effective only in guinea-pigs sensitized to produce at least partly IgE-like antibodies; aminophylline was effective in guinea-pigs sensitized to produce both IgE and/or IgG antibodies. 3 The results in vivo with SCG were reflected in vitro by a reduced capacity of chopped lung tissue to release histamine at antigen challenge; lungs from animals treated with aminophylline did not show reduced histamine releasing capacity. 4 Acute treatment with atropine was shown to reduce significantly the antigen-induced bronchial contraction in guinea-pigs sensitized to produce both IgE- and IgG-antibodies. No effect of atropine was seen on an IgG-mediated anaphylaxis. 5 Increased reactivity to methacholine but not to histamine was seen in guinea-pigs sensitized to produce both IgG- and IgE-antibodies. Long-term treatment with SCG did not affect this hyperreactivity to methacholine. 6 Decreased reactivity to isoprenaline was found in isolated tracheae taken from guinea-pigs sensitized to produce both IgE- and IgG-like antibodies compared to unsensitized guinea-pigs. Long-term treatment with SCG, but not with aminophylline, reversed this decreased reactivity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170376      PMCID: PMC2071757          DOI: 10.1111/j.1476-5381.1981.tb10470.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

1.  Mechanics of respiration in unanesthetized guinea pigs.

Authors:  M O AMDUR; J MEAD
Journal:  Am J Physiol       Date:  1958-02

2.  Differential effects of homocytotropic antibodies on the mast cell and anaphylactic responses in actively and passively sensitized mice.

Authors:  J B Barnett; D E Justus
Journal:  Infect Immun       Date:  1975-06       Impact factor: 3.441

3.  Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.

Authors:  R P Orange; W G Austen; K F Austen
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

Review 4.  Review of clinical activity and mode of action of sodium cromoglycate.

Authors:  R E Altounyan
Journal:  Clin Allergy       Date:  1980-07

Review 5.  Auto-modulation of release of pharmacological mediators of immediate (type I) hypersensitivity. A review.

Authors:  M C Holroyde; J F Burka; P Eyre
Journal:  Agents Actions       Date:  1977-10

Review 6.  Some pharmacological aspects of xanthines in asthma.

Authors:  C G Persson
Journal:  Eur J Respir Dis Suppl       Date:  1980

7.  The effects of sodium cromoglycate on histamine aerosol-induced reflex bronchoconstriction in the anaesthetized dog.

Authors:  D M Jackson; I M Richards
Journal:  Br J Pharmacol       Date:  1977-10       Impact factor: 8.739

8.  Effect of disodium cromoglycate and Picrorhiza kurroa root powder on sensitivity of guinea pigs to histamine and sympathomimetic amines.

Authors:  S S Mahajani; R D Kulkarni
Journal:  Int Arch Allergy Appl Immunol       Date:  1977

9.  Role of bronchial irritant receptors in asthma.

Authors:  M G Harries; P E Parkes; M H Lessof; T S Orr
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

10.  Antigen-induced bronchial anaphylaxis in actively sensitized guinea-pigs: anti-anaphylactic effects of sodium cromoglycate and aminophylline.

Authors:  P Andersson
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

View more
  17 in total

Review 1.  Pharmacological studies of pulmonary anaphylaxis in vitro: a review.

Authors:  P O Ogunbiyi; P Eyre
Journal:  Agents Actions       Date:  1985-12

2.  Rocastine (AHR-11325), a rapid acting, nonsedating antihistamine.

Authors:  J C Nolan; D J Stephens; A G Proakis; C A Leonard; D N Johnson; B F Kilpatrick; M H Foxwell; J M Yanni
Journal:  Agents Actions       Date:  1989-08

3.  Blockade by methylation inhibitors of the anaphylactic response of guinea-pig lung strips.

Authors:  J Randon; J Lefort; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

Review 4.  Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease.

Authors:  E M Sorkin; A Ward
Journal:  Drugs       Date:  1986-02       Impact factor: 9.546

Review 5.  Cromolyn.

Authors:  B A Berman; R N Ross
Journal:  Clin Rev Allergy       Date:  1983-03

6.  Effects of inhibitors of anaphylactic mediators in two models of bronchial anaphylaxis in anaesthetized guinea-pigs.

Authors:  P Andersson
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

7.  Immunohistochemical evidence for mast cells containing 5-hydroxytryptamine in rat portal vein.

Authors:  F Barja; R Mathison; C Kursner
Journal:  Agents Actions       Date:  1986-08

8.  Protective effects of the glucocorticoid, budesonide, on lung anaphylaxis in actively sensitized guinea-pigs: inhibition of IgE-but not of IgG-mediated anaphylaxis.

Authors:  P Andersson; R Brattsand
Journal:  Br J Pharmacol       Date:  1982-05       Impact factor: 8.739

9.  Receptor-specific mediation by immunoglobulin E of antigen-induced contraction of tracheal and lung parenchymal strips isolated from the guinea pig.

Authors:  F M Graziano; L Gundersen; L A Larson; P Harley; C K Buckner
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 10.  Drug treatment of allergic conjunctivitis. A review of the evidence.

Authors:  G Ciprandi; S Buscaglia; P M Cerqueti; G W Canonica
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.